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Abstract 
Background: We aim to assess the incidence, current treatment and 
outcome of diverticulitis in highly immunosuppressed lung transplant 
recipients. Methods: Retrospective analysis of a prospective database of 403 
lung transplant recipients transplanted between 1992 and 2013 with a mean 
follow-up of 99 months (SD 58.0). Results: 4.46% of lung transplant 
recipients (n=18) developed diverticulitis. Eight lung transplant recipients 
developed uncomplicated diverticulitis, which were all treated successfully 
with antibiotics. Three patients (37.5%) underwent elective sigmoid resection 
with severe Grade 3b complications after two of five (40%) surgical 
procedures. Diverticulitis recurrence occurred in five patients (60%). In total 
10 lung transplant recipients presented with 11 episodes of perforated 
diverticulitis with a 30-day mortality rate of 9.1%. Hartmann procedure was 
performed in 8 lung transplant recipients. Sigmoid resection with primary 
anastomosis and protective ileostomy was performed in 3 patients with 
Hinchey I. Two of these patients developed anastomotic leakage with a 
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secondary Hartmann procedure. Conclusion: Due to high leakage rate after 
resection with primary anastomosis and protective ileostomy in our cohort of 
lung transplant recipients with perforated diverticulitis, the Hartmann 
procedure seems to be the safer option. In contrast, in uncomplicated 
diverticulitis non-operative treatment can be considered as a safe and highly 
successful treatment option, even for recurrences. 
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 Introduction 
Diverticular disease is a very common condition in Western societies 
with increasing prevalence. Complications of diverticular disease are acute 
uncomplicated diverticulitis and complicated diverticulitis including perforation 
as well as diverticular bleeding (1). To date, limited data is available on the 
natural history of diverticulitis in immunosuppressed patients. The incidence of 
acute diverticulitis appears higher in immunosuppressed patients and 
development of complicated disease seems more likely (2, 3). 
It remains unclear, whether the recurrence rate after an uncomplicated 
episode is also higher in this population. A recent study found no difference in 
recurrence rate and the authors did not detect a significant difference in 
emergency surgery for recurrent disease in immunosuppressed vs. non-
immunosuppressed patients(4). However, current guidelines recommend a 
low threshold for early elective surgery in immunosuppressed patients(5). 
Mortality and morbidity in emergency surgery have been shown to be 
significantly higher in immunosuppressed organ transplant recipients 
compared to their matched controls (3). These differences in mortality or 
morbidity were not observed following elective surgery in immunosuppressed 
patients with diverticulitis (3). This was supported by data from a large 
nationwide retrospective review of colorectal surgeries in kidney transplant 
recipients, showing a low mortality and morbidity in kidney transplant patients 
undergoing colorectal surgery (6).  This might be due to a better preoperative 
health compared to other solid organ recipients as well as the need for 
intensified immunosuppression after heart or lung transplantation compared to 
kidney transplantation (3).  
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Receiving intensified (triple-) immunosuppression and given their close follow-
up and the availability of data, we aimed to study the natural history of 
diverticulitis in lung transplant recipients. Specifically we aimed to critically 
analyze the paradigm to keep a low threshold for elective surgery in 
uncomplicated diverticulitis in immunosuppressed patients.
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Materials and Methods 
Ethical approval  
All procedures performed in studies involving human participants were 
in accordance with the ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki declaration and its later 
amendments or comparable ethical standards. For this type of study formal 
consent is not required. 
Data  
We retrospectively analyzed the prospective database of 403 lung 
transplant recipients at our institution between January 1992 and December 
2013 and assessed patients with perforated and uncomplicated diverticulitis. 
We analyzed age, gender, symptoms at time of diagnosis, time from lung 
transplant to colonic complication, time from onset of symptoms to treatment,  
laboratory values, radiologic findings, degree of colon complication, treatment 
of colonic complication, immunosuppression at presentation, change of 
immunosuppressive treatment, antibiotic treatment pre- and post- diagnosis, 
non-operative or surgical treatment strategy, morbidity, hospital stay, length of 
follow up and 30-day mortality. We also evaluated whether colonoscopies 
were performed prior to transplantation to assess preexisting diverticular 
disease. 
 
Definitions 
All lung transplant recipients with spontaneous lower abdominal pain 
and/ or tender abdomen upon palpation received either a CT scan or an MRI 
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for further workup. The diagnosis was made when inflamed diverticula with 
inflamed surrounding fatty tissue were detected on a CT-scan or MRI(7). In 
one patient diagnosis of a recurrent episode of non-perforated diverticulitis 
was based on clinical presentation, x-ray and sonography. We considered 
diverticulitis with any extraluminal air in the imaging as perforated diverticulitis. 
In contrast we defined diverticulitis without signs of perforation as 
uncomplicated diverticulitis episodes.  
Statistical analysis 
All mean values and standard deviations (8) as well as median values 
and range measurements were calculated by Microsoft excel for Mac 2011, 
Version 14.3.9. Data are expressed as mean with SD or median with range. 
Mann-Whitney-U tests were performed to compare the experimental groups. 
Differences were considered statistically significant if p<0.05. Analyses were 
conducted using Graph Pad prism Version 4.0b.
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Results 
Patient demographics and incidence of diverticulitis 
Between November 1992 and December 2013 a total of 18 of 403 lung 
transplant recipients (4.47%) developed diverticulitis during a mean follow up 
(FU) after transplantation of 99.8 months (SD 58.0) (median 110 months; 
range 9-208), as diagnosed by CT scan or MRI (Suppl Table 1A,1B). Our 
local transplant unit requires colonoscopy as part of pretransplant workup only 
in patients 50 years and older or in individuals with gastrointestinal complaints 
or positive family history for intestinal disease. Thus only 5/18 patients 
underwent a colonoscopy before transplantation, which documented a 
diverticulosis in all five cases. However, none of the 18 patients had 
experienced an episode of diverticulitis before transplantation. Ten of 18 lung 
transplant recipients with diverticulitis had 11 episodes of perforated 
diverticulitis at a mean time of 60.6 months (SD 66.3) after lung 
transplantation (Table 3). Perforations occurred within 1 year of 
transplantation in 36.4% (4/11) of cases. The mean age at the time of 
diverticular perforation was 59.4 years (SD 7.0) (Table 3). Mean FU after 
colonic perforation was 27.9 months (SD 42.2) (Table 3). At presentation one 
of these patients was hypotensive and required catecholamines. The 
remaining cases were normotensive. Two of eleven patients were tachycardic 
and two patients had fever (>38.5°C). Time from symptoms to treatment 
varied between 0.5 days and 3 days (mean 1.65 days, SD 1.0). The reason 
for transplantation were Langerhans-Histocytosis (n=1), pulmonary 
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emphysema due to AT1-deficiency (n=6), endstage COPD (n=1), severe 
pulmonary hypertension (n=1) and cystic fibrosis (n=1).  
In addition, eight lung transplant recipients had 12 episodes of uncomplicated 
diverticulitis at a mean FU of 122.8 months (SD 30.0) post transplant. The 
average age of these patients at time of the diverticular episode was 63 years 
(Table 3). Mean FU after uncomplicated diverticulitis episode was 61.7 
months (SD 23.9)  (Table 3). Patients with uncomplicated diverticulitis were 
normotensive (n=5) or hypertensive (n=7). Two patients with uncomplicated 
disease presented with fever. Time between symptoms and treatment varied 
between 0.5 and 6 days (mean 2.31 days, SD 1.95). 
The underlying diagnoses leading to lung transplantation in patients with 
uncomplicated diverticulitis were chronic obstructive lung disease (n=4), 
alpha-1-AT-deficiency with lung emphysema (n=2), idiopathic lung fibrosis 
(n=1), and Kartagener-Syndrome (n=1).  
With exception of one patient who received tacrolimus instead of cyclosporine 
due to insufficiently controllable drug levels within the first month after 
transplantation, all patients received cyclosporine, mycophenolate and 
prednisone (Table 4). The immunosuppression regime did not change over 
time. Immunosuppression was not routinely changed upon the diagnosis of 
diverticulitis. However, in case of expected surgical intervention we routinely 
reduced mycophenolate by 1/3 to 1/2 of the dose. If differential blood count 
showed a trend towards cytopenia we further reduced the mycophenolate 
dose to avoid neutropenia (9). 
Treatment and Outcome of Complicated Diverticulitis 
 11 
Of the 10 patients presenting with 11 episodes of perforated 
diverticulitis all were treated surgically. HP was performed in 8 patients with 
Hinchey I(n=1), II(n=1), III(n=3) and IV(n=3). The remaining 3 cases all with 
Hinchey I(n=3) had a colonic resection with anastomosis and protective 
ileostomy in 2/3 cases. Two of these three cases occurred in the same patient 
with 32 months between both resections. Due to the short interval between 
the two episodes, the reason for recurrence is most likely an incomplete 
resection of the high-pressure zone. While the primary anastomosis healed in 
the first episode, a leakage of the descendorectostomy occurred six days after 
the second surgery, necessitating an end colostomy. The third patient was 
primarily treated with a diagnostic laparoscopy, lavage and drainage followed 
by resection with primary anastomosis six days later. This patient developed 
an anastomotic leakage four days later, which required a resection with end-
colostomy. Although the three cases treated with primary anastomosis only 
had a Hinchey stage I diverticulitis, two required a secondary HP due to 
anastomotic leakage (Table 1). Taken together, 91% (10/11) of the cases with 
a perforated diverticulitis received a HP and two out of three (66.7%) patients 
with a primary anastomosis developed a major grade 3b complication 
according to the Clavien-Dindo Classification(10) after resection and 
anastomosis. No organ failure or death occurred, however. Of the 8 patients 
primarily treated with HP five (63%) developed a severe (≥grade 3b) 
complication. Single or multiorgan failure occurred in three patients (grade 
4a,b) and one patient died (grade 5) within 30 days resulting in a 30-day 
mortality of 9.1% after perforated sigmoid diverticulitis. Another two patients 
died within 2 and 4.5 months after surgery (Table 1).  
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Overall median hospital stay amounted to 24.5 days (range 14-133), with a 
median length of stay of 41 days (range 14-133) in patients with HP versus 24 
days (range 23-27) in the patients primarily treated with anastomosis.  
Thus in our experience of 3 cases, performing a primary anastomosis in 
highly immunosuppressed patients with a perforated sigmoid diverticulitis, 
even in Hinchey I situations, the risk for anastomotic leakage is extremely 
high. 
Colostomy reversal 
Only 20% (2/10) of patients with colostomy have had a reversal of the 
colostomy at 16 and 7 months after the primary surgery within a mean FU of 
21.9 months (SD 40.5) after primary or secondary HP. Of the two colostomy 
reversals one had postoperative self-limiting anal bleeding without endoscopic 
signs of leakage (grade 1 complication). In the second patient with colostomy 
reversal and in one patient with ileostomy reversal no complications occurred. 
None of these patients died upon reversal. Of the remaining 8 patients 3 died 
and 5 still had a colostomy at the end of our observation period, which was at 
a mean of 8.3 months (SD 5.8) after the HP.  
Thus, only a minority of patients have a colostomy reversal with a reasonable 
postoperative morbidity. 
Treatment and Outcome of Uncomplicated Diverticulitis   
Of the 8 LTRs with uncomplicated diverticulitis all were treated 
successfully with broad spectrum i.v. antibiotics and oral food intake 
restriction. Three of these patients received elective resection at a mean of 
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2.25 months after the diverticulitis episode. Of the remaining 5 patients, 3 
(60%) developed an uncomplicated recurrence within 1 (n=2) and 8.5 months 
(n=1). One patient developed another uncomplicated re-recurrence 27 
months later. All recurrences were again successfully treated with antibiotics  
(Figure 1). There were no complications during the hospitalization with a 
mean hospitalization time of 10.7 days (SD 4.3).  
Thus, we found a high recurrence rate of uncomplicated diverticulitis in 
lung transplant recipients, all of which were treated successfully with i.v. 
antibiotics. 
Two of three patients with an elective resection underwent a laparoscopic 
resection with primary anastomosis and protective ileostomy and one patient 
had an open resection with primary anastomosis. Both ileostomies were 
reversed at 2.5 and 5.5 months after placement. One stoma prolapse and one 
anastomotic insufficiency upon ileostomy reversal occurred, both requiring 
surgery.  
Thus, after three elective sigmoid resections and two subsequent elective 
ileostomy-reversals, two (40%) 3b complications occurred (Figure 2). The 
involved surgeons were all board certified according to the federation of swiss 
surgeons (FMH) and had been consultants at the abdominal surgery 
department of the University Hospital of Zurich for at least 4 years at the time 
of surgery. 
The mean total hospitalization duration of these patients with elective surgical 
treatment was 39.3 days (SD 34). This was not significantly different from the 
mean hospitalization time of 26 days (SD 17.4) in the patients with 
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uncomplicated diverticulitis without elective resection, when recurrence and 
bleeding episodes were included (p=0.39) (Table 2).  
Of note, one patient with elective laparoscopic resection, protective ileostomy 
and ileostomy reversal with an entirely uneventful course presented with a 
rectum perforation most probably due to a perforated diverticulum 6 years 
after sigmoid resection.  
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Discussion  
In this monocentric study we analyze the incidence and outcome of 
sigmoid diverticulitis in a large number of lung transplant recipients with a long 
follow-up and no loss to follow-up. Our study includes complicated- and 
uncomplicated diverticulitis and thus surgical- and non-surgical treatment, 
giving an idea of the natural history of the disease in immunosuppressed 
patients. During a mean follow-up of 8.3 years, 4.5% of our lung transplant 
recipients developed diverticulitis. This corresponds to an extrapolated 
incidence of 550 per 100,000 lung transplant recipients, which is about 15 
times higher than in the non-immunosuppressed population, where 
diverticulitis is responsible for approximately 25 to 50 hospital admissions per 
100,000 people per year(11),(12). The diverticulitis rate is identical to a 
recently published paper on diverticulitis in lung transplant recipients with a 
short follow-up of 442 days (4.5%)(13) and higher than in pooled data from 
other transplanted organs, where it was 1.7%(14). This may be due to the 
lower level of immunosuppression compared to other types of organ 
transplantation. Furthermore, consistent with previous data in 
immunosuppressed patients(2),(15) the majority (55.6%) of our lung 
transplant recipients  presented with perforated sigmoid diverticulitis at their 
first episode as opposed to the non-immunosuppressed population where 
only 37.7%(16) of patients have been shown to present with perforation at 
their initial episode. Time from symptoms to treatment was not longer in the 
complicated- versus the uncomplicated diverticulitis group and the majority of 
patients even with complicated diverticulitis were normotensive, afebrile and 
cardiopulmonary stable. Thus, we exclude deterioration of an initially 
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uncomplicated diverticulitis as cause for this relatively high prevalence of 
complicated disease. This is in line with the theory, that complicated- and 
uncomplicated diverticulitis are etiologically two different diseases (17, 18).  
 
All patients with perforated sigmoid diverticulitis were treated surgically. 
Interestingly, despite a positive selection of patients with Hinchey I 
diverticulitis receiving a primary anastomosis, primary anastomosis failed in 
two of three cases, ultimately leading to a HP rate of 90.9%.  This suggests 
that immunosuppressed patients with perforated diverticulitis irrespective of 
their Hinchey stage may benefit from a discontinuity resection.  
In the non-immunosuppressed population, selection criteria of patients for 
elective sigmoid resection after an uncomplicated episode of diverticulitis 
remain unclear. Recent studies have shown that patients with more than two 
episodes are not at an increased risk for complications as compared to 
patients with fewer episodes(19). In contrast, in transplant patients non-
operative treatment - including antibiotics and short term food restriction - is 
thought to have a high failure rate, leading to a high mortality(2). In our 
population 37.5% (3/8) of lung transplant recipients received an elective 
sigmoid resection after the first episode of uncomplicated diverticulitis, as 
compared to around 7%(20) of non-immunosuppressed patients. Our policy to 
have a low threshold for elective surgery following the first episode of 
uncomplicated diverticulitis in immunosuppressed patients is in line with the 
current recommendation of the ASCRS(5). However, the analysis of our lung 
transplant recipient cohort does not seem to support this practice for the 
following reasons:  Firstly, although the recurrence rate after the first 
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uncomplicated diverticulitis in lung transplant recipients was higher than in the 
non-immunosuppressed population (60% vs. 13%- 20%) (20), all recurrences 
were successfully treated with i.v. antibiotics, with no additional morbidity 
other than re-recurrence and diverticular bleeding in two patients. In particular 
none of the patients presented with perforation at a further episode of 
diverticulitis. Secondly, lung transplant recipients with elective resection 
required up to two elective surgical procedures (e.g resection and stoma 
reversal). Importantly, additional emergency surgery was required in two of 
five elective procedures due to grade 3b complications. Furthermore, surgical 
treatment did not reduce total hospitalization time and lastly, as mentioned 
above resection could not fully prevent a second episode with perforation.  
 The observation, that elective procedures in immunosuppressed patients with 
organ transplantation have a high morbidity in the elective setting is not in line 
with previous studies that found no difference in morbidity or mortality after 
elective colorectal surgeries in organ recipients as compared to matched 
controls (3). Further, none of our patients with uncomplicated diverticulitis 
presented with a perforated diverticulitis to a later timepoint. Although in other 
studies the percentage was low, it was not zero (3).  
In conclusion, the results of our study have to be interpreted with caution 
given the small number of patients. However, in line with the current literature 
and recommendations, our data confirms the higher incidence of diverticulitis-, 
as well as the higher rate of perforated diverticulitis in lung transplant 
recipients. Due to high leakage rate after resection with primary anastomosis 
and protective ileostomy in our cohort of lung transplant recipients with 
perforated diverticulitis the Hartmann procedure may be the safer option. In 
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contrast to previous findings we observed that uncomplicated diverticulitis in 
lung transplant recipients can be successfully treated using a non-operative 
approach even in recurrences thus avoiding morbidity of elective surgery. 
Ultimately, these findings might change recommendations towards a higher 
threshold for elective surgery in immunosuppressed patients. Bigger studies 
evaluating the risk of perforation at recurrence against the morbidity of 
elective surgery, as well as more data on the role of primary anastomosis in 
lung transplant recipients with perforated diverticulitis are needed to ultimately 
answer these questions. 
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